Iovance Biotherapeutics (IOVA) Misses Q3 EPS by 1c

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q3 EPS of ($0.46), $0.01 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• KB Home (KBH) PT Lowered to $50 at RBC Capital
• TD Cowen on Alaska Air (ALK): 'Can Alaska ReAccelerate?'